featured
Combined High-Dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-Dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
Eur Urol 2021 Jul 08;[EPub Ahead of Print], S Supiot, L Vaugier, D Pasquier, X Buthaud, N Magné, D Peiffert, P Sargos, G Crehange, P Pommier, G Loos, A Hasbini, I Latorzeff, M Silva, F Denis, JL Lagrange, C Morvan, L Campion, A Blanc-LapierreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.